Factors Associated with Central Venous Catheterization in Cancer Patients.
- Author:
Jeong Yun PARK
1
;
Yeon Hwan PARK
Author Information
- Publication Type:Original Article
- Keywords: Central venous catheterization; Hospitalization; Neoplasms
- MeSH: Catheterization, Central Venous; Catheters; Central Venous Catheters; Hematologic Diseases; Hospitalization; Humans; Length of Stay; Retrospective Studies
- From:Journal of Korean Oncology Nursing 2011;11(1):1-8
- CountryRepublic of Korea
- Language:Korean
- Abstract: PURPOSE: The purpose of this study was to identify the types of venous access devices (VAD) for cancer patients and investigate the factors related to the insertions of central venous catheter (CVC) in cancer patients. METHODS: The subjects were 379 cancer patients. A retrospective review of all patients who were discharged from a cancer unit from November 1st to 21st in 2008 was done using a structured questionnaire. RESULTS: A total of 82 CVC (21.6%) was inserted among 379 patients for administering anticancer therapy. There were statistically significant differences in age, length of stay (LOS), cumulative LOS, medical department, history of CVC insertion, cancer category, and albumin level between patients using peripheral intravenous (IV) catheters and CVC. In addition, factors influencing the use of CVC were LOS (odds ratio [OR]=0.286, confidence interval [CI]=1.043-1.124), history of CVC insertion (OR=3.920, CI=0.128-0.637), albumin level (OR=1.010, CI=1.879-8.179), cumulative LOS (OR=1.010, CI=1.001-1.018), and hematological diseases (OR=4.863, CI=2.162-10.925). CONCLUSION: We found that central venous catheterization for anticancer therapy was minimal even though CVC was safe and effective device for IV access. It is necessary to develop a strategy to use VADs efficiently and timely for cancer patients.
